Shoulder Arthroplasty in Hemophilia.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40151583.
- Also identified by DOI 10.22038/ABJS.2024.80320.3667 and PMC identifier 11938361.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this article is to perform a review of the literature on the current status of shoulder arthroplasty in people with hemophilia (PWH). A search was conducted in PubMed on December 8, 2024, using the keywords "hemophilia" and "shoulder arthroplasty." To date only 4 articles (84 shoulder arthroplasties) in PWH have been published. A recent study with level 3 of evidence has found that five-year implant survival was similar in PWH (97.3%) than in matched controls (95.2%) suggesting that total shoulder arthroplasty (TSA) survivorship endures lasting and might be proposed to PWH. However, the high risks of both 90-day bleeding complication and venous thromboembolism (VTE) in PWH stressed the special dares of scrupulously weighing factor replacement and VTE prophylaxis pre-, intra-, and postoperatively on an individual patient basis with cautious hematologist coordination.
Anatomy
- shoulder